120 related articles for article (PubMed ID: 38147481)
1. Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors.
Baković M; Bago M; Benić L; Krajinović M; Silovski T; Plavetić ND; Turković L; Sertić M; Hadžiabdić MO
Acta Pharm; 2023 Dec; 73(4):633-654. PubMed ID: 38147481
[TBL] [Abstract][Full Text] [Related]
2. Beliefs about medicines' association with endocrine therapy adherence in early breast cancer survivors in Croatia.
Okroša AD; Silovski T; Plavetić ND; Silovski H; Kovačić A; Mucalo I
Acta Pharm; 2023 Dec; 73(4):673-689. PubMed ID: 38147479
[TBL] [Abstract][Full Text] [Related]
3. The relationship between medication adherence and illness perception in breast cancer patients with adjuvant endocrine therapy: beliefs about medicines as mediators.
Zhao M; Zhao J; Chen J; Li M; Zhang L; Luo X; Zhang Y; Xiong C; Guo Z; Yan J
Support Care Cancer; 2022 Dec; 30(12):10009-10017. PubMed ID: 36261611
[TBL] [Abstract][Full Text] [Related]
4. Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer.
Salgado TM; Davis EJ; Farris KB; Fawaz S; Batra P; Henry NL
Breast Cancer Res Treat; 2017 Jun; 163(2):311-319. PubMed ID: 28251384
[TBL] [Abstract][Full Text] [Related]
5. Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group.
Fountzilas E; Koliou GA; Vozikis A; Rapti V; Nikolakopoulos A; Boutis A; Christopoulou A; Kontogiorgos I; Karageorgopoulou S; Lalla E; Tryfonopoulos D; Boukovinas I; Rapti C; Nikolaidi A; Karteri S; Moirogiorgou E; Binas I; Mauri D; Aravantinos G; Zagouri F; Saridaki Z; Psyrri A; Bafaloukos D; Koumarianou A; Res E; Linardou H; Mountzios G; Razis E; Fountzilas G; Koumakis G
ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32817060
[TBL] [Abstract][Full Text] [Related]
6. Influence of patients' disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine.
Sweileh WM; Zyoud SH; Abu Nab'a RJ; Deleq MI; Enaia MI; Nassar SM; Al-Jabi SW
BMC Public Health; 2014 Jan; 14():94. PubMed ID: 24479638
[TBL] [Abstract][Full Text] [Related]
7. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Gao JJ; Cheng J; Bloomquist E; Sanchez J; Wedam SB; Singh H; Amiri-Kordestani L; Ibrahim A; Sridhara R; Goldberg KB; Theoret MR; Kluetz PG; Blumenthal GM; Pazdur R; Beaver JA; Prowell TM
Lancet Oncol; 2020 Feb; 21(2):250-260. PubMed ID: 31859246
[TBL] [Abstract][Full Text] [Related]
8. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
[No Abstract] [Full Text] [Related]
9. Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension--a primary care study.
Maguire LK; Hughes CM; McElnay JC
Patient Educ Couns; 2008 Nov; 73(2):371-6. PubMed ID: 18692978
[TBL] [Abstract][Full Text] [Related]
10. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.
Lin C; Clark R; Tu P; Bosworth HB; Zullig LL
Breast Cancer Res Treat; 2017 Sep; 165(2):247-260. PubMed ID: 28573448
[TBL] [Abstract][Full Text] [Related]
12. Patients' Perception of App-based Educational and Behavioural Interventions for Enhancing Oral Anticancer Medication Adherence.
Ali EE; Leow JL; Chew L; Yap KY
J Cancer Educ; 2018 Dec; 33(6):1306-1313. PubMed ID: 28707206
[TBL] [Abstract][Full Text] [Related]
13. Specific, but not general beliefs about medicines are associated with medication adherence in patients with COPD, but not asthma: Cohort study in a population of people with chronic pulmonary disease.
Fischer W; Brandstetter S; Brandl M; Finger T; Böhmer MM; Pfeifer M; Apfelbacher C
J Psychosom Res; 2018 Apr; 107():46-52. PubMed ID: 29502763
[TBL] [Abstract][Full Text] [Related]
14. Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach.
Tan EH; Wong ALA; Tan CC; Wong P; Tan SH; Ang LEY; Lim SE; Chong WQ; Ho J; Lee SC; Tai BC
Breast Cancer Res Treat; 2021 Aug; 188(3):779-788. PubMed ID: 33948777
[TBL] [Abstract][Full Text] [Related]
15. Using the extended self-regulatory model to characterise diabetes medication adherence: a cross-sectional study.
Shiyanbola OO; Unni E; Huang YM; Lanier C
BMJ Open; 2018 Nov; 8(11):e022803. PubMed ID: 30478112
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive PET Imaging of CDK4/6 Activation in Breast Cancer.
Ramos N; Baquero-Buitrago J; Ben Youss Gironda Z; Wadghiri YZ; Reiner T; Boada FE; Carlucci G
J Nucl Med; 2020 Mar; 61(3):437-442. PubMed ID: 31481582
[TBL] [Abstract][Full Text] [Related]
17. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder.
Emilsson M; Gustafsson PA; Öhnström G; Marteinsdottir I
Eur Child Adolesc Psychiatry; 2017 May; 26(5):559-571. PubMed ID: 27848023
[TBL] [Abstract][Full Text] [Related]
18. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Chen J; Mao JJ
Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
[TBL] [Abstract][Full Text] [Related]
19. Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis.
Gao JJ; Cheng J; Prowell TM; Bloomquist E; Tang S; Wedam SB; Royce M; Krol D; Osgood C; Ison G; Sridhara R; Pazdur R; Beaver JA; Amiri-Kordestani L
Lancet Oncol; 2021 Nov; 22(11):1573-1581. PubMed ID: 34656225
[TBL] [Abstract][Full Text] [Related]
20. Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.
Tan EH; Wong ALA; Tan CC; Wong P; Tan SH; Ang LEY; Lim SE; Chong WQ; Ho J; Lee SC; Tai BC
J Health Psychol; 2022 Apr; 27(5):1111-1124. PubMed ID: 33550864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
